Dimensional Fund Advisors’s Sight Sciences SGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.08M Buy
383,512
+41,831
+12% +$193K ﹤0.01% 2736
2026
Q1
$1.29M Buy
341,681
+40,346
+13% +$218K ﹤0.01% 2792
2025
Q4
$2.39M Sell
301,335
-2,299
-0.8% -$14.7K ﹤0.01% 2701
2025
Q3
$1.04M Buy
303,634
+3,051
+1% +$11.4K ﹤0.01% 2887
2025
Q2
$1.24M Buy
300,583
+2,686
+0.9% +$8.96K ﹤0.01% 2851
2025
Q1
$716K Buy
297,897
+53,943
+22% +$152K ﹤0.01% 2944
2024
Q4
$887K Buy
243,954
+108,001
+79% +$492K ﹤0.01% 2939
2024
Q3
$857K Buy
135,953
+57,321
+73% +$386K ﹤0.01% 2935
2024
Q2
$524K Sell
78,632
-5,234
-6% -$30.9K ﹤0.01% 3020
2024
Q1
$443K Hold
83,866
– – ﹤0.01% 3064
2023
Q4
$433K Sell
83,866
-12,945
-13% -$39.9K ﹤0.01% 3057
2023
Q3
$326K Sell
96,811
-63,754
-40% -$419K ﹤0.01% 3124
2023
Q2
$1.33M Buy
160,565
+39,426
+33% +$355K ﹤0.01% 2877
2023
Q1
$1.06M Buy
+121,139
New +$1.34M ﹤0.01% 2889

Other funds holding SGHT

Dimensional Fund Advisors's SGHT Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Sight Sciences (SGHT) stake by 12% in Q2 2026, buying an estimated $193K and bringing the position to 383,512 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2736.

Dimensional Fund Advisors first reported a position in SGHT in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.39M in Q4 2025. 112 funds tracked by Wall St. Rank hold SGHT as of Q2 2026.

  • Dimensional Fund Advisors held 383,512 shares of Sight Sciences worth $2.08M as of Q2 2026.
  • Dimensional Fund Advisors bought 41,831 Sight Sciences shares in Q2 2026, an estimated $193K.
  • Sight Sciences made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2736 holding.
  • Dimensional Fund Advisors first reported a position in Sight Sciences in Q1 2023 and has held it in 14 quarters since.
  • Dimensional Fund Advisors's Sight Sciences position peaked at $2.39M in Q4 2025.
  • 112 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.